Similar articles

• Cerebral microbleeds: evidence of heightened risk associated with aspirin use.

  Gorelick PB. Gorelick PB. Arch Neurol. 2009 Jun;66(6):691-3. doi: 10.1001/archneurol.2009.85. Arch Neurol. 2009. PMID: 19506128 No abstract available.
• Aspirin resistance: is it real? Is it clinically significant?

  Dalen JE. Dalen JE. Am J Med. 2007 Jan;120(1):1-4. doi: 10.1016/j.amjmed.2006.08.023. Am J Med. 2007. PMID: 17208069 No abstract available.
• [Multiple cerebral haemorrhages and antiplatelet drugs].

  Rubí-Callejón J, Arjona A, Serrano-Castro PJ. Rubí-Callejón J, et al. Rev Neurol. 2004 Sep 16-30;39(6):600; author reply 600. Rev Neurol. 2004. PMID: 15468007 Spanish. No abstract available.
• Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials.

  Berger JS, Lala A, Krantz MJ, Baker GS, Hiatt WR. Berger JS, et al. Am Heart J. 2011 Jul;162(1):115-24.e2. doi: 10.1016/j.ahj.2011.04.006. Am Heart J. 2011. PMID: 21742097 Review.
• Aspirin in cardiology--benefits and risks.

  Björklund L, Wallander MA, Johansson S, Lesén E. Björklund L, et al. Int J Clin Pract. 2009 Mar;63(3):468-77. doi: 10.1111/j.1742-1241.2008.01908.x. Int J Clin Pract. 2009. PMID: 19222632 Review.